Immunology
Conference Coverage
Oral immunotherapy desensitizes youth with peanut allergy
After 12 months, most participants aged 4-17 years who received the drug were able to eat a dose of 600 mg or more of peanut protein.
Conference Coverage
Olopatadine/mometasone combo is safe and effective
ORLANDO – Combining two safe and effective options for seasonal allergic rhinitis showed even more efficacy with relative safety.
From the Journals
JAK inhibitors look good for severe alopecia areata treatment
Adolescents may benefit the most from this new therapy.
Latest News
Birth cohort affected 2015-2016 flu vaccine effectiveness
Birth year may have an impact on how well the influenza vaccine worked.
From the Journals
Tdap during pregnancy, or before, offers infants pertussis protection
Many women still don’t receive Tdap during pregnancy.
Conference Coverage
Immunologic testing is key to diagnosing autoimmune blistering diseases
SAN FRANCISCO – Starting with immunologic testing can spare patients with blistering diseases years of unnecessary overexposure to prednisone.
From the Journals
Study indicates parent-reported penicillin allergy in question
Children with low-risk penicillin allergy may be in the clear.
From the Journals
Meningococcal B, C vaccines together lead to adequate immune response
Can you administer a meningitis B vaccine at the same time as a meningitis C vaccine?
From the Journals
High allele level linked to lamotrigine-induced SCAR
Could higher frequency of alleles associated with drug-induced severe cutaneous adverse reactions be specific to ethnicity?
From the Journals
Lower-dose aluminum hydroxide–adjuvanted polio vaccine noninferior to standard IPV
New reduced-dose inactivated poliovirus vaccines may be low-cost alternatives for low-resource countries in the future.
From the Journals
Adalimumab is good first-line anti-TNF therapy for pediatric Crohn’s disease
Consider adalimumab as a first-line anti–tumor necrosis factor treatment for Crohn’s disease in children.